Position in ENTA
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$8,402,208
-$1,725,286 QoQ
Shares Held
665,258
+3.6% QoQ
Ownership
2.29%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ENTA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,450,872,574 across 330 Biotechnology names. ENTA ranks #62 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,726,993 | $588,750,729 | |
| 2 | INCY |
Incyte Corp
|
3,651,532 | $343,682,191 | |
| 3 | CORT |
Corcept Therapeutics Inc
|
5,682,783 | $229,072,982 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
421,688 | $188,300,559 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
819,374 | $154,902,654 | |
| 6 | GMAB |
Genmab A/S
|
4,414,550 | $118,442,376 | |
| 7 | INVA |
Innoviva, Inc.
|
4,055,632 | $94,496,225 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
1,036,495 | $64,988,236 |
All Filings in ENTA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,402,208 | 665,258 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $10,127,494 | 642,200 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $5,740,812 | 479,600 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $3,549,420 | 469,500 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $2,559,072 | 463,600 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,863,500 | 498,000 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $5,437,964 | 524,900 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $6,626,373 | 510,900 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $9,185,706 | 526,100 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $5,255,485 | 558,500 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $5,116,977 | 458,100 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $10,192,820 | 476,300 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $17,286,644 | 427,464 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $22,013,264 | 473,200 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $24,275,160 | 468,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $25,658,156 | 542,800 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $43,213,378 | 607,100 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $53,422,832 | 714,400 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $42,981,593 | 756,585 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $35,108,009 | 797,728 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $44,397,864 | 900,200 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $43,527,190 | 1,033,900 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $47,107,620 | 1,029,000 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $47,343,009 | 942,900 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $45,289,258 | 880,600 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||